Skip to main content

Clinical Trials

The Canadian Cancer Trials Group (CCTG) supports national and international multicentre phase I-III cancer clinical research trials aimed at improving the survival and quality of life of cancer patients across all cancer types. The scientific agenda for the group is developed by clinical researchers across Canada and beyond, includes trials of new cancer agents, novel radiation and surgical techniques, as well as interventions to improve patient quality of life.

If you are a CCTG member and need to access the full trials pages please click here.

The links below will take you to pages that list all the current CCTG trials with a brief description. If you are interested in volunteering for a trial we suggest that you discuss the opportunity with your care team.

If you are a patient or caregiver and are looking for other information about clinical trials a complete listing of clinical trials being conducted in Canada, including the locations where they are being conducted, can be found here: Canadian Cancer Trials.  And if you are interested in learning about participating in a clinical trial more information can be found here: www.itstartswithme.ca

 

How can I participate in a clinical trial

 

How can I participate in a clinical trial

EN12 RAINBO-ORANGE successful CIHR Project Grant funding

EN12 RAINBO-ORANGE successful CIHR Project Grant funding

The EN12 RAINBO-ORANGE clinical trial was awarded $1,575,898 through the CIHR Project Grant to investigate if surgery followed by radiotherapy and a type of oral endocrine therapy called progestins will lead to similar cancer control as surgery followed by radiotherapy and chemotherapy in patients with NSMP, estrogen receptor-positive endometrial cancer (EC).

More >>
 
New study SC31 TEMPO testing an online program to support people with prostate cancer and their caregivers

The new SC31 TEMPO study is testing an online support program for people with prostate cancer and their caregivers

The SC31 TEMPO trial is now open and evaluating an innovative online program designed to help people with prostate cancer and their caregivers better manage the physical and emotional challenges associated with cancer and its treatment.

More >>
 
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer

CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer

CCTG, EORTC and UK3CR welcome the G7 Leaders’ announcement recognizing cancer as a global priority.

More >>
 
New LYC.2 Trial Opens for Patients with Peripheral T-Cell Lymphoma

New LYC.2 trial opens for patients with peripheral T-cell lymphoma

Now opened in Canada for patients with PTCL, investigating whether an intensive treatment approach can reduce the risk of the disease returning after initial chemotherapy.

More >>